| Non-demented DS (DS-) | Demented DS (DS+) | Healthy controls (HC) | Significance |
---|---|---|---|---|
N = 85 | n = 35 | n = 11 | n = 39 |  |
Demographics, mean (percent) | Â | Â | Â | Â |
 Male no. | 26 (74%) | 6 (55%) | 24 (62%) | p = 0.358a |
 Age, mean (SD) | 35 (12) | 52 (6) | 35 (12) | p < 0.001b |
Cognitive measures | Â | Â | Â | Â |
 CAMCOG (total) score | 56 (22) | 32 (21) | 119 (3) | p < 0.001b |
 CAMCOG (short-term memory) score | 12 (7) | 5 (4) | 22 (2) | p < 0.001b |
MRI VOI proportions | Â | Â | Â | Â |
 Grey proportion (average R and L) | 0.76 (0.07) | 0.75 (0.11) | 0.72 (0.08) | p = 0.187b |
 White proportion (average R and L) | 0.24 (0.07) | 0.25 (0.11) | 0.28 (0.08) | p = 0.187b |
Mean CSF (R) | 0.13 (0.07) | 0.15 (0.04) | 0.07 (0.04) | p = 0.000b |
Mean CSF (L) | 0.10 (0.07) | 0.17 (0.09) | 0.07 (0.04) | p = 0.006b |
Mean metabolite concentration | Â | Â | Â | Â |
 Glx (R hippocampus) | 38.89 (6.13) | 41.04 (4.16) | 38.49 (7.03) | p = 0.309c |
 Glx (L hippocampus) | 36.51 (5.25) | 36.56 (7.20) | 36.59 (5.72) | p = 0.955c |
 Glx (average of R and L) | 38.14 (5.61) | 38.41 (4.71) | 37.57 (5.16) | p = 0.853c |